|
Market Cap (25-Jun) $80,439,416 (1,515th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 402,075 |
Shortsold (10-Feb) 29,568 (0.00%) (623rd) |
|
52w High $0.027 |
52w Low $0.003 |
P/E 4.78 |
EPS 0 |
AVE released this announcement to the ASX on 30 April 2021, 14:10. The announcement is not marked as price sensitive, and is 26 page(s) in length and 654.93kb in size.
You can view all announcements from AVE and see how they appear on a price chart on the announcements page.
At the date of this announcement, AVE was 0.088% short sold according to ASIC data. It was ranked the 437th most shorted stock on the ASX. It remains ranked 623rd as of the latest reported data (10 February 2025).
| Other Recent Announcements from AVE | |
|---|---|
| Update - Application for quotation of securities - AVE | 28 June 2023, 11:48 |
| Application for quotation of securities - AVE | 28 June 2023, 11:43 |
| AVE CBD capsule passes two-year stability milestone | 22 June 2023, 8:57 |
| Notice of Annual General Meeting/Proxy Form | 30 April 2021, 14:10 |
| March 2021 Quarterly Activities Report & Appendix 4C | 28 April 2021, 16:10 |
| Avecho receives ethics approval for CBD human trial | 13 April 2021, 8:57 |
| Appendix 4G and Corporate Governance Statement | 26 March 2021, 9:55 |
You must be logged in to post a reply.
Avecho Biotechnology 